PSIL Holdings Information

PSIL is an equity ETF with a total of 30 individual holdings. The top holdings are AtaiBeckley stock at 10.29%, COMPASS Pathways at 9.33%, Definium Therapeutics at 9.15%, Relmada Therapeutics at 7.58%, and Alkermes at 6.61%.

Total Holdings

Top 10 Percentage

71.31%

Asset Class

Equity

ETF Category

Miscellaneous Sector

Assets

20.54M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ATAI	AtaiBeckley Inc.	10.29%	567,587
2	CMPS	COMPASS Pathways plc	9.33%	261,739
3	DFTX	Definium Therapeutics, Inc.	9.15%	108,901
4	RLMD	Relmada Therapeutics, Inc.	7.58%	338,872
5	ALKS	Alkermes plc	6.61%	44,269
6	NEO: HELP	Cybin Inc.	6.10%	161,604
7	GHRS	GH Research PLC	6.03%	79,334
8	NBIX	Neurocrine Biosciences, Inc.	5.63%	8,870
9	ANRO	Alto Neuroscience, Inc.	5.33%	56,823
10	SUPN	Supernus Pharmaceuticals, Inc.	5.27%	19,453
11	CSE: DRUG	Bright Minds Biosciences Inc.	4.91%	11,813
12	ABBV	AbbVie Inc.	4.11%	3,765
13	JNJ	Johnson & Johnson	4.00%	3,378
14	NRXP	NRx Pharmaceuticals, Inc.	3.48%	370,467
15	NEUP	Neuphoria Therapeutics Inc.	3.15%	148,627
16	STIM	Neuronetics, Inc.	2.36%	342,193
17	KTTA	Pasithea Therapeutics Corp.	1.37%	337,508
18	SILO	Silo Pharma, Inc.	1.23%	663,965
19	CSE: QNTM	Quantum BioPharma Ltd.	1.11%	63,591
20	TSX: NUMI	Numinus Wellness Inc.	0.86%	5,359,413
21	VTGN	Vistagen Therapeutics, Inc.	0.81%	277,110
22	IXHL	Incannex Healthcare Inc.	0.60%	735,097
23	n/a	Blackrock Treasury Trust Instl 62	0.47%	95,814
24	ENVB	Enveric Biosciences, Inc.	0.19%	16,974
25	CMND	Clearmind Medicine Inc.	0.04%	7,357

Showing 25 of 30 holdings

Subscribe to see the full list

Activate Now

As of Feb 26, 2026